Deciphera Pharmaceuticals is a leading biopharmaceutical company based in Waltham, MA, dedicated to improving the lives of cancer patients. With a strong focus on research and development, they design switch-control kinase inhibitors to target and regulate cellular function, aiming to enhance patient responses to treatment and ultimately improve outcomes.
Driven by a commitment to defeating cancer, Deciphera Pharmaceuticals has developed a diverse pipeline of drug candidates that address key mechanisms of tumor and drug resistance. Their innovative approach and dedication to making a difference in patients' lives set them apart in the fight against cancer.
Generated from the website